The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,868,282 in first-year total cost, median $934,141.
Most frequent study sections
- Special Emphasis Panel[ZAI1 SAS-M (J1)]2
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- SCANOGEN, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Rapid, Breath Volatile Metabolite-Based Diagnosis, Species Identification, and Antibiotic Resistance Profiling in Bacterial Pneumonia1R01AI175040-01 | KOO, SOPHIA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,001,442 | ZAI1 |
| 2023 | Rapid ID and AST Directly from Whole Blood Using Single Molecule Detection1R01AI175063-01 | CELEDON, ALFREDO ANDRES | SCANOGEN, INC., MD | $866,840 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.